BackLumiraDx Limited - Units (1 Ord Class A & 1/2 War) Overview

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) Current Cash

Track LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s current cash ($620K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$623676.00

Peer average

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) Current Cash History

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) vs. peers: Current Cash Comparison

Loading

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

LumiraDx Limited - Units (1 Ord Class A & 1/2 War) (CAHCU) FAQ

As of the most recent data (June 2021), CAHCU shows a current cash of $620K. Scroll down for historical charts and peer comparison views.

Tracking CAHCU's current cash over time shows whether LumiraDx Limited - Units (1 Ord Class A & 1/2 War) is scaling, shrinking, or reshaping that part of the business. The current reading is $620K Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $620K) with ownership activity and broader fundamentals.

LumiraDx Limited - Units (1 Ord Class A & 1/2 War)'s current cash is $620K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.